Cargando…

Heterogeneity in potential COVID-19 vaccine-related AEs

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211951/ http://dx.doi.org/10.1007/s40278-021-97467-3

Ejemplares similares

Systemic AEs common after COVID-19 vaccination
Publicado: (2022)

Acute neurological AEs after COVID-19 vaccination
Publicado: (2022)

AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
Publicado: (2021)

AEs after homologous versus heterologous COVID-19 booster
Publicado: (2022)

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

COVID-19 vaccination relatively safe in autoimmune diseases
Publicado: (2022)

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021)

Standardised assessment of COVID-19 vaccine-related skin reactions
Publicado: (2022)

COVID-19 vaccine AE reports in Australia and New Zealand
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021)

FAPIC score predicts mortality after COVID-19 vaccine-related TTS
Publicado: (2021)

Systematic review: COVID-19 vaccine-related neurological disorders "exceedingly" rare
Publicado: (2022)

PRAC May 2021 meeting highlights: COVID-19 vaccine AEs
Publicado: (2021)

PRAC June 2021 meeting highlights: COVID-19 vaccine AEs
Publicado: (2021)

Most adolescent myocarditis cases related to covid-19 vaccines mild, resolve quickly
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine: AEs after vaccination in New Zealand
Publicado: (2021)

WTP for COVID-19 vaccine in Chile
Publicado: (2021)

TTS with Janssen's COVID-19 vaccine
Publicado: (2021)

AES-Comments on AES offer
por: Gerard, M
Publicado: (1986)

COVID-19-related decreases in paediatric PCV 13 use does not justify vaccination of older adults
Publicado: (2021)

Public's willingness to wait for COVID-19 vaccine
Publicado: (2021)

Predicted uptake of COVID-19 vaccination in USA
Publicado: (2021)

Willingness to pay for COVID-19 vaccination in China
Publicado: (2021)

COVID-19 vaccination safe during pregnancy
Publicado: (2021)

Thrombocytopenia and thromboembolism after COVID-19 vaccination
Publicado: (2021)

Anxiety disorders with Janssen's COVID-19 vaccine
Publicado: (2021)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

COVID-19 vaccination predicted to be cost effective in USA
Publicado: (2021)

COVID-19 vaccines safe in people living with HIV
Publicado: (2022)

Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects
por: Uebelhack, Ralf, et al.
Publicado: (2019)

Demand for potentially hazardous COVID-19 treatments
Publicado: (2020)

Demand for potentially hazardous COVID-19 treatments
Publicado: (2020)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

Productivity losses impact cost effectiveness of COVID-19 vaccine
Publicado: (2021)

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)

Cerebral venous sinus thrombosis after COVID-19 vaccination
Publicado: (2021)

COVID-19 vaccine adverse events reported via app
Publicado: (2021)

COVID-19 vaccination during pregnancy: no increase in placental lesions
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rf1qarr3cde555lsd9g97jc39n